RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.36660%2Fabc.20210832
https://w3id.org/ripe/ripe-kg/work/10.36660%2Fabc.20210832
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1016%2Fj.lana.2022.100268Hydroxychloroquine for COVID19: The curtains close on a comedy of errors |
http://purl.org/spar/cito/cites |
ripekg:work/10.36660%2Fabc.20210832Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
ripekg:work/10.36660%2Fabc.20210832Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
prism:doi |
10.36660/abc.20210832 |
ripekg:work/10.36660%2Fabc.20210832Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
dcterms:title |
Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
ripekg:work/10.36660%2Fabc.20210832Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
rdf:type |
node1 |
ripekg:work/10.36660%2Fabc.20210832Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.36660%2Fabc.20210832Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
rdf:type |
rdfs:Resource |
ripekg:work/10.36660%2Fabc.20210832Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
rdf:type |
owl:Thing |
ripekg:work/10.36660%2Fabc.20210832Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
rdf:type |
prov:Entity |
ripekg:work/10.36660%2Fabc.20210832Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
rdf:type |
ripe:WorkWork |
ripekg:work/10.36660%2Fabc.20210832Rationale and design of the COVID-19 outpatient prevention evaluation (COPE) randomized clinical trial: hydroxychloroquine vs. placebo in non-hospitalized patients |
owl:sameAs |
https://semopenalex.org/work/W4212830227 |